Sweet taste receptor agonists alter ovarian functions and ovarian cycles in aged mice

Kavita Ngekure M X1, Jingle Jiang1, Hamdard Enayatullah1

  • 1College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.

Reproductive Biology
|August 11, 2019
PubMed

Insights

Artificial sweeteners like saccharin sodium and rebaudioside A negatively impact aged mice reproduction, affecting ovarian cycles, causing apoptosis, and altering biochemical markers. Further research is needed to understand these reproductive health effects.

Area of Science:

  • Reproductive Biology
  • Endocrinology
  • Toxicology

Background:

  • Low-calorie sweeteners, saccharin sodium and rebaudioside A, interact with sweet taste receptors.
  • Limited data exists on the reproductive effects of these sweeteners in aged animals.

Purpose of the Study:

  • To investigate the impact of saccharin sodium and rebaudioside A on the reproductive system of aged mice.
  • To assess effects on ovarian cycles, ovulation, and related biochemical parameters.

Main Methods:

  • Thirty-six aged mice were divided into control, saccharin sodium, and rebaudioside A groups for 30 days.
  • Evaluated estrous cycles, uterine weight, corpora lutea, and performed apoptosis assays (TUNEL, AIF).
  • Measured serum glucose, cholesterol, and progesterone levels.

Main Results:

  • Sweeteners did not alter body weight but increased uterine weight and abnormal estrous cycles.
  • Apoptosis was confirmed in granulosa cells, oocytes, and corpora lutea.
  • Elevated serum glucose, progesterone, and cholesterol were observed in treatment groups.

Conclusions:

  • Saccharin sodium and rebaudioside A consumption negatively affects reproductive indices in aged mice.
  • These sweeteners may induce reproductive toxicity through apoptosis and metabolic changes.

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.5K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.5K
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
4.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
861
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
909